Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-002820
Accepted
2024-09-13 00:15:07
Documents
1
Effectiveness Date
2024-09-12
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-24-002820.txt   2080
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-281873 | Film No.: 241296356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)